Skin Cancer Hub

Skin Cancer Hub

Videos

Dr. Matthew Hadfield shares considerations for diagnosing and managing immunotherapy-related adverse events.
b2ap3_large_Video-Expert-Perspectives-Richard-Carvajal-MD_960x800-compressed-1
Dr. Christine Ko shares her passion for incorporating cognitive psychology and emotional intelligence into medicine.
Dr. Richard Carvajal shares his passions for melanoma research and providing high-quality local cancer care.
Dr. Shaheer Khan shares the results of two trials of cemiplimab and pembrolizumab for cutaneous squamous cell carcinoma.
b2ap3_large_NL-2022-Video-Interview-Richard-Carvajal-MD-960-800-px

News

b2ap3_large_Melanoma_CNS_met_smear_HE-compressed
b2ap3_large_Melanoma_CNS_met_smear_HE-compressed
The FDA has approved melphalan for injection as a liver-directed treatment for patients with uveal melanoma.
Retifanlimab has received accelerated FDA approval for metastatic/recurrent locally advanced Merkel cell carcinoma.
i3 Health provided an educational activity that provided knowledge gains for treating patients with Merkel cell carcinoma.
Dr. Karl Lewis explores the data from the EMPOWER-BCC 1 trial of cemiplimab for metastatic basal cell carcinoma.

Podcasts

b2ap3_large_Podcast-Expert-Perspectives-Richard-Carvajal-MD_960x800-compressed-1
Dr. Richard Carvajal shares his passions for melanoma research and providing high-quality local cancer care.
Danet Peterson talks about her work with A Cure in Sight, an organization to support patients with ocular melanoma.
In this podcast, Dr. Shaheer Khan shares the impactful results of recent developments in treatment of cutaneous squamous cell carcinoma.
Dr. Richard Carvajal discusses the recent groundbreaking approval of tebentafusp for patients with uveal melanoma.